Related Experiment Video
Updated: Mar 29, 2026
07:59
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.8K
Sequencing study on familial lung squamous cancer.
Shaomin Li1, Lina Wang2, Zhenchuan Ma1
1Department of Thoracic Surgery, Second Affiliated Hospital, Medical School, Xi'an Jiaotong University, Xi'an, Shaanxi 710004, P.R. China.
Oncology Letters
|December 2, 2015
Summary
Researchers identified two genetic variants in PDE4DIP and CLTCL1 genes in a Chinese family with multiple lung squamous carcinoma cases. This study offers insights into hereditary lung cancer and its genetic underpinnings.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Lung cancer is a leading cause of cancer mortality globally.
- Most lung cancers are sporadic, with familial cases being rare and understudied.
- Previous research has primarily focused on sporadic lung cancer, identifying numerous driver genes.
Purpose of the Study:
- To investigate the genetic basis of hereditary lung squamous carcinoma in a Chinese family.
- To identify causative mutations in familial lung cancer cases.
Main Methods:
- Whole exome sequencing (WES) was performed on a lung squamous carcinoma patient's blood sample.
- Identified variants were validated in additional family members.
- Data analysis involved approximately 2.0 Gb of sequencing data with an average depth of 60x.
Main Results:
- Two functional variants were identified in cancer-related genes: c.1218delA:p.E406fs in PDE4DIP and C1342A:p.L448I in CLTCL1.
- These variants are implicated in the development of lung squamous carcinoma within the studied family.
Conclusions:
- The study identified novel genetic variants potentially linked to hereditary lung cancer.
- These findings provide a foundation for further research into the mechanisms of familial lung cancer.
